Alison E. McGonagle
Impact in
- Organic Chemistry top 10%
- Catalytic C–H Functionalization Methods
-
- PARP inhibition in cancer therapy
Papers in
-
- Epigenetics and DNA Methylation 4
- Histone Deacetylase Inhibitors Research 4
- Cancer therapeutics and mechanisms 2
- Cancer-related gene regulation 2
- DNA Repair Mechanisms 1
-
- Organometallic Complex Synthesis and Catalysis 1
- Co-authors
- Stephen P. Marsden (1 shared paper)Allan M. Jordan (9 shared papers)Daniel P. Mould (6 shared papers)Emma L. Williams (1 shared paper)Daniel H. Wiseman (1 shared paper)Donald Ogilvie (8 shared papers)Helen Small (5 shared papers)James R. Hitchin (4 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (3 papers)Journal of Medicinal Chemistry (3 papers)ACS Chemical Biology (1 paper)Medicinal Research Reviews (1 paper)Australian Journal of Chemistry (1 paper)
- Partner nations
- United KingdomAustraliaFrance
In The Last Decade
Alison E. McGonagle
11 papers receiving 495 citations
Peers
Comparison fields: 5 of 57
- Organic Chemistry 181
- Oncology 127
- Molecular Biology 317
- Physiology 20
- Toxicology 9
Countries citing papers authored by Alison E. McGonagle
This map shows the geographic impact of Alison E. McGonagle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison E. McGonagle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison E. McGonagle more than expected).
Fields of papers citing papers by Alison E. McGonagle
This network shows the impact of papers produced by Alison E. McGonagle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison E. McGonagle. The network helps show where Alison E. McGonagle may publish in the future.
Co-authors
The 25 scholars most cited alongside Alison E. McGonagle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 131 | |
| 2 | 2014 | 108 | |
| 3 | 2016 | 97 | |
| 4 | 2013 | 55 | |
| 5 | 2017 | 42 | |
| 6 | 2018 | 27 | |
| 7 | 2017 | 13 | |
| 8 | 2009 | 12 | |
| 9 | 2017 | 10 | |
| 10 | 2014 | 2 | |
| 11 | 2019 | 1 |
About Alison E. McGonagle
Alison E. McGonagle is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Immunology and Pharmaceutical Science, having authored 11 papers that have together received 498 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Histone Deacetylase Inhibitors Research (4 papers), PARP inhibition in cancer therapy (3 papers), Cancer therapeutics and mechanisms (2 papers), Cancer-related gene regulation (2 papers), Acute Myeloid Leukemia Research (1 paper), DNA Repair Mechanisms (1 paper) and Organometallic Complex Synthesis and Catalysis (1 paper). The work is most often cited by research in Organic Chemistry (181 citations), Oncology (127 citations), Molecular Biology (317 citations), Physiology (20 citations) and Toxicology (9 citations). Alison E. McGonagle has collaborated with scholars based in United Kingdom, Australia and France. Frequent co-authors include Stephen P. Marsden, Allan M. Jordan, Daniel P. Mould, Emma L. Williams, Daniel H. Wiseman, Donald Ogilvie, Helen Small, James R. Hitchin, Bohdan Waszkowycz and Nicola Hamilton. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, ACS Chemical Biology, Medicinal Research Reviews and Australian Journal of Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.